Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.
High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosis.
Self-rated health in women prior to clinical onset of multiple sclerosis: A study within the Danish National Birth Cohort.
Micro RNA-155 participates in re-activation of encephalitogenic T cells.
[Pathology of the Peripheral Nervous System in Guillain-Barré Syndrome].
Fatigue during multiple sclerosis relapse and its relationship to depression and neurological disability.
Depletion of Olig2 in oligodendrocyte progenitor cells infected by Theiler's murine encephalomyelitis virus.
[Structural and functional changes of the hippocampus in patients with multiple sclerosis and their relationship with memory processes].
Genetic variation associated with the occurrence and progression of neurological disorders.
Intractable vomiting as an initial presentation of lupus-related neuromyelitis optica.
PreImplantation Factor bolsters neuroprotection via modulating Protein Kinase A and Protein Kinase C signaling.
Lentivirus-Mediated RNA Interference Targeting RhoA Slacks the Migration, Proliferation, and Myelin Formation of Schwann Cells.
High-resolution myelin water imaging in post-mortem multiple sclerosis spinal cord: A case report.
Chronic Severe Hyponatremia and Cardiopulmonary Bypass: Avoiding Osmotic Demyelination Syndrome.
Recent advances in the biomedical applications of fumaric acid and its ester derivatives: The multifaceted alternative therapeutics.
T cell repertoire following autologous stem cell transplantation for multiple sclerosis.
Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine.
Characterization of the NT2-derived neuronal and astrocytic cell lines as alternative in vitro models for primary human neurons and astrocytes.
Smoking and multiple sclerosis susceptibility.
Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM Evaluation of: Gold R, Kappos L, Arnold D, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012;
Macular spectral domain optical coherence tomography findings in Tanzanian endemic optic neuropathy.
Multiple sclerosis, natalizumab, and PML: helping patients decide.
Optimizing JC and BK polyomavirus IgG testing for seroepidemiology and patient counseling.
DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT.
Imaging in Pediatric Demyelinating and Inflammatory Diseases of the Brain- Part 1.

Pages